Skip to main content
See every side of every news story
Published • loading... • Updated

Blood Biomarker Helps Estimate a Person's Future Risk of Cognitive Impairment

The blood test combines p-tau217 with age, sex and APOE ε4 status to estimate risk, with higher levels linked to greater decline.

Summary by News Medical
A blood biomarker for Alzheimer's disease may help estimate a cognitively healthy person's risk of developing mild cognitive impairment or dementia over the next five or 10 years, according to a new Mayo Clinic study in JAMA Neurology.

4 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Newswise broke the news in Charlottesville, United States on Monday, November 16, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal